Fate Therapeutics Inc (FATE.OQ)

FATE.OQ on NASDAQ Stock Exchange Global Market

5.16USD
17 Sep 2014
Price Change (% chg)

$-0.21 (-3.91%)
Prev Close
$5.37
Open
$5.40
Day's High
$5.40
Day's Low
$5.16
Volume
1,680
Avg. Vol
4,192
52-wk High
$13.50
52-wk Low
$4.32

FATE.OQ

Chart for FATE.OQ

About

Fate Therapeutics, Inc, is a clinical-stage biopharmaceutical company engaged in the discovery and development of pharmacologic modulators of adult stem cells to treat orphan diseases, including hematologic malignancies, lysosomal storage disorders and muscular dystrophies. Its approaches utilize pharmacologic modalities,... (more)

Overall

Beta: --
Market Cap (Mil.): $106.10
Shares Outstanding (Mil.): 20.56
Dividend: --
Yield (%): --

Financials

  FATE.OQ Industry Sector
P/E (TTM): -- 143.76 33.47
EPS (TTM): -5.74 -- --
ROI: -132.37 -2.42 17.39
ROE: -- -7.11 18.25
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks